Animal-derived Immune Globulin Products - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509240512

Publication Date:

September 24, 2024

Pages:

104

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Immune globulin听(Ig) short-term protection against hepatitis A and measles
The global market for Animal-derived Immune Globulin Products was estimated to be worth US$ 1241 million in 2023 and is forecast to a readjusted size of US$ 1726.3 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030
North American market for Animal-derived Immune Globulin Products was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Animal-derived Immune Globulin Products was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Animal-derived Immune Globulin Products was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Animal-derived Immune Globulin Products include Pfizer, Rare Disease Therapeutics, Bioclon Institute, Merck & Co, Sanofi and BTG Specialty Pharmaceuticals, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Animal-derived Immune Globulin Products, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Animal-derived Immune Globulin Products by region & country, by Type, and by Application.
The Animal-derived Immune Globulin Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal-derived Immune Globulin Products.
麻豆原创 Segmentation
By Company
Pfizer
Rare Disease Therapeutics
Bioclon Institute
Merck & Co
Sanofi
BTG Specialty Pharmaceuticals
Segment by Type:
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
By Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Animal-derived Immune Globulin Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Animal-derived Immune Globulin Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Animal-derived Immune Globulin Products in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Animal-derived Immune Globulin Products Product Introduction
1.2 Global Animal-derived Immune Globulin Products 麻豆原创 Size Forecast
1.2.1 Global Animal-derived Immune Globulin Products Sales Value (2019-2030)
1.2.2 Global Animal-derived Immune Globulin Products Sales Volume (2019-2030)
1.2.3 Global Animal-derived Immune Globulin Products Sales Price (2019-2030)
1.3 Animal-derived Immune Globulin Products 麻豆原创 Trends & Drivers
1.3.1 Animal-derived Immune Globulin Products Industry Trends
1.3.2 Animal-derived Immune Globulin Products 麻豆原创 Drivers & Opportunity
1.3.3 Animal-derived Immune Globulin Products 麻豆原创 Challenges
1.3.4 Animal-derived Immune Globulin Products 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Animal-derived Immune Globulin Products Players Revenue Ranking (2023)
2.2 Global Animal-derived Immune Globulin Products Revenue by Company (2019-2024)
2.3 Global Animal-derived Immune Globulin Products Players Sales Volume Ranking (2023)
2.4 Global Animal-derived Immune Globulin Products Sales Volume by Company Players (2019-2024)
2.5 Global Animal-derived Immune Globulin Products Average Price by Company (2019-2024)
2.6 Key Manufacturers Animal-derived Immune Globulin Products Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Animal-derived Immune Globulin Products Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Animal-derived Immune Globulin Products
2.9 Animal-derived Immune Globulin Products 麻豆原创 Competitive Analysis
2.9.1 Animal-derived Immune Globulin Products 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Animal-derived Immune Globulin Products Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal-derived Immune Globulin Products as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 IVIg Liquid
3.1.2 IVIg Powder
3.2 Global Animal-derived Immune Globulin Products Sales Value by Type
3.2.1 Global Animal-derived Immune Globulin Products Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Animal-derived Immune Globulin Products Sales Value, by Type (2019-2030)
3.2.3 Global Animal-derived Immune Globulin Products Sales Value, by Type (%) (2019-2030)
3.3 Global Animal-derived Immune Globulin Products Sales Volume by Type
3.3.1 Global Animal-derived Immune Globulin Products Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Animal-derived Immune Globulin Products Sales Volume, by Type (2019-2030)
3.3.3 Global Animal-derived Immune Globulin Products Sales Volume, by Type (%) (2019-2030)
3.4 Global Animal-derived Immune Globulin Products Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Immunodeficiency
4.1.2 Autoimmune Disease
4.1.3 Acute Infection
4.2 Global Animal-derived Immune Globulin Products Sales Value by Application
4.2.1 Global Animal-derived Immune Globulin Products Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Animal-derived Immune Globulin Products Sales Value, by Application (2019-2030)
4.2.3 Global Animal-derived Immune Globulin Products Sales Value, by Application (%) (2019-2030)
4.3 Global Animal-derived Immune Globulin Products Sales Volume by Application
4.3.1 Global Animal-derived Immune Globulin Products Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Animal-derived Immune Globulin Products Sales Volume, by Application (2019-2030)
4.3.3 Global Animal-derived Immune Globulin Products Sales Volume, by Application (%) (2019-2030)
4.4 Global Animal-derived Immune Globulin Products Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Animal-derived Immune Globulin Products Sales Value by Region
5.1.1 Global Animal-derived Immune Globulin Products Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Animal-derived Immune Globulin Products Sales Value by Region (2019-2024)
5.1.3 Global Animal-derived Immune Globulin Products Sales Value by Region (2025-2030)
5.1.4 Global Animal-derived Immune Globulin Products Sales Value by Region (%), (2019-2030)
5.2 Global Animal-derived Immune Globulin Products Sales Volume by Region
5.2.1 Global Animal-derived Immune Globulin Products Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Animal-derived Immune Globulin Products Sales Volume by Region (2019-2024)
5.2.3 Global Animal-derived Immune Globulin Products Sales Volume by Region (2025-2030)
5.2.4 Global Animal-derived Immune Globulin Products Sales Volume by Region (%), (2019-2030)
5.3 Global Animal-derived Immune Globulin Products Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Animal-derived Immune Globulin Products Sales Value, 2019-2030
5.4.2 North America Animal-derived Immune Globulin Products Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Animal-derived Immune Globulin Products Sales Value, 2019-2030
5.5.2 Europe Animal-derived Immune Globulin Products Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Animal-derived Immune Globulin Products Sales Value, 2019-2030
5.6.2 Asia Pacific Animal-derived Immune Globulin Products Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Animal-derived Immune Globulin Products Sales Value, 2019-2030
5.7.2 South America Animal-derived Immune Globulin Products Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Animal-derived Immune Globulin Products Sales Value, 2019-2030
5.8.2 Middle East & Africa Animal-derived Immune Globulin Products Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Animal-derived Immune Globulin Products Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Animal-derived Immune Globulin Products Sales Value
6.2.1 Key Countries/Regions Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.2.2 Key Countries/Regions Animal-derived Immune Globulin Products Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.3.2 United States Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Animal-derived Immune Globulin Products Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.4.2 Europe Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Animal-derived Immune Globulin Products Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.5.2 China Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
6.5.3 China Animal-derived Immune Globulin Products Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.6.2 Japan Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Animal-derived Immune Globulin Products Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.7.2 South Korea Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Animal-derived Immune Globulin Products Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.8.2 Southeast Asia Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Animal-derived Immune Globulin Products Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.9.2 India Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
6.9.3 India Animal-derived Immune Globulin Products Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Animal-derived Immune Globulin Products Product Offerings
7.1.5 Pfizer Recent Development
7.2 Rare Disease Therapeutics
7.2.1 Rare Disease Therapeutics Company Information
7.2.2 Rare Disease Therapeutics Introduction and Business Overview
7.2.3 Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Rare Disease Therapeutics Animal-derived Immune Globulin Products Product Offerings
7.2.5 Rare Disease Therapeutics Recent Development
7.3 Bioclon Institute
7.3.1 Bioclon Institute Company Information
7.3.2 Bioclon Institute Introduction and Business Overview
7.3.3 Bioclon Institute Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Bioclon Institute Animal-derived Immune Globulin Products Product Offerings
7.3.5 Bioclon Institute Recent Development
7.4 Merck & Co
7.4.1 Merck & Co Company Information
7.4.2 Merck & Co Introduction and Business Overview
7.4.3 Merck & Co Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Merck & Co Animal-derived Immune Globulin Products Product Offerings
7.4.5 Merck & Co Recent Development
7.5 Sanofi
7.5.1 Sanofi Company Information
7.5.2 Sanofi Introduction and Business Overview
7.5.3 Sanofi Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sanofi Animal-derived Immune Globulin Products Product Offerings
7.5.5 Sanofi Recent Development
7.6 BTG Specialty Pharmaceuticals
7.6.1 BTG Specialty Pharmaceuticals Company Information
7.6.2 BTG Specialty Pharmaceuticals Introduction and Business Overview
7.6.3 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
7.6.4 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Product Offerings
7.6.5 BTG Specialty Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Animal-derived Immune Globulin Products Industrial Chain
8.2 Animal-derived Immune Globulin Products Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Animal-derived Immune Globulin Products Sales Model
8.5.2 Sales Channel
8.5.3 Animal-derived Immune Globulin Products Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Pfizer
Rare Disease Therapeutics
Bioclon Institute
Merck & Co
Sanofi
BTG Specialty Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.